Literature DB >> 22067405

Induction of cutaneous squamous cell carcinomas by RAF inhibitors: cause for concern?

Mario E Lacouture1, Kathryn O'Reilly, Neal Rosen, David B Solit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22067405     DOI： 10.1200/JCO.2011.38.2895

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

1.  Resolution of lung adenocarcinoma after discontinuation of ibrutinib.

Authors:  Tamer Khashab; Sanam Loghavi; Sergej N Konoplev; Felipe Samaniego
Journal:  BMJ Case Rep       Date:  2016-07-18

Review 2.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

3.  Multiplying therapies and reducing toxicity in metastatic melanoma.

Authors:  Paul R Massey; Vinay Prasad; William D Figg; Tito Fojo
Journal:  Cancer Biol Ther       Date:  2015-05-27       Impact factor: 4.742

Review 4.  Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy.

Authors:  Jeremy S Logue; Deborah K Morrison
Journal:  Genes Dev       Date:  2012-04-01       Impact factor: 11.361

5.  Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study.

Authors:  Emily Y Chu; Karolyn A Wanat; Christopher J Miller; Ravi K Amaravadi; Leslie A Fecher; Marcia S Brose; Suzanne McGettigan; Lydia R Giles; Lynn M Schuchter; John T Seykora; Misha Rosenbach
Journal:  J Am Acad Dermatol       Date:  2012-05-18       Impact factor: 11.527

Review 6.  Targeting TGF-β Signaling for Therapeutic Gain.

Authors:  Rosemary J Akhurst
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

Review 7.  Vemurafenib-induced progression of breast cancer: a case report and review of the literature.

Authors:  Aleksei V Novik; Svetlana A Protsenko; Irina A Baldueva; Aleksander O Ivantsov; Tatyana L Nekhaeva; Zinaida Y Akhaeva; Grigoriy A Yanus; Aglaya G Iyevleva; Evgeny N Imyanitov
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

Review 8.  Safe handling of oral antineoplastic medications: Focus on targeted therapeutics in the home setting.

Authors:  Yaakov Cass; Thomas H Connor; Alexander Tabachnik
Journal:  J Oncol Pharm Pract       Date:  2016-03-22       Impact factor: 1.809

9.  Latest approved therapies for metastatic melanoma: what comes next?

Authors:  Farid Menaa
Journal:  J Skin Cancer       Date:  2013-02-24

Review 10.  The dynamic nature of the kinome.

Authors:  Lee M Graves; James S Duncan; Martin C Whittle; Gary L Johnson
Journal:  Biochem J       Date:  2013-02-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.